Preparation methods and application of semicarbazide SEM derived hapten and artificial antigen

A technology of nitrofurazone and artificial antigen, applied in the field of immunochemistry, can solve the problem that the SEM hapten cannot completely retain the characteristic structure of the competitor, and achieve the effects of enhanced immunogenicity, enhanced structural characteristics, and high sensitivity

Inactive Publication Date: 2017-06-13
广州润坤生物科技有限公司
View PDF12 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The technical problem to be solved by the present invention is to overcome the defect that the traditional SEM hapten cannot completely retain the characteristic structure of the competitor, and provide a preparation method and application of a nitrofurazone metabolite SEM derivatized hapten and artificial antigen, which can retain the competitor Nitro-terminal haptens, artificial antigens, improve competitor specificity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation methods and application of semicarbazide SEM derived hapten and artificial antigen
  • Preparation methods and application of semicarbazide SEM derived hapten and artificial antigen
  • Preparation methods and application of semicarbazide SEM derived hapten and artificial antigen

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Such as Figure 1-5 As shown, the nitrofurazone metabolite SEM derivatized hapten of the present embodiment 1 is prepared by the following method, and the steps are as follows:

[0050] (a') Dissolve 2.0g (ie 7.1mmol) of compound I in 10ml of ethanol, adjust the pH value of compound I's ethanol solution to 10-12 through 6mol / L lithium hydroxide solution, and react at room temperature for 15-26h , add 40ml of purified water, adjust the pH value of the resulting solution to 4-5 with 1M dilute hydrochloric acid, filter, and dry to obtain 1.1g of compound II.

[0051] ESI-MS: 167[M-CH2CH2CH2COOH-1], 252[M-1], 288[M+2H2O-1], 315[2×167-H2O-1], 505[2M-1], 537[2M +MeOH-1];

[0052] 1H NMR (600MHz, CDCl 3 , TMS): δ10.50(s, 1H), 8.20(d, 1H), 7.35(d, 1H), 7.15-7.19(dd, 1H), 4.23(t, 2H), 2.66(t, 2H), 2.26 (m, 2H).

[0053] (b') Dissolve 0.5g (i.e. 2.0mmol) of compound II in 10ml of methanol, add 0.18g (i.e. 2.4mmol) of nitrofurazone metabolite SEM, react at 60-70°C for 2h, aft...

Embodiment 2

[0057] Example 2 is an artificial antigen of nitrofurazone metabolites. The artificial antigen includes an immunogen and a coating source. The difference between the two is that the types of carrier proteins coupled during the preparation process are different. For the prepared hapten, the carrier protein is bovine serum albumin (BSA); the coating source is the hapten prepared in Example 1, and the carrier protein is ovalbumin (OVA).

[0058] The coating former of the nitrofurazone metabolite of present embodiment 2 is prepared by the following method, and its steps are as follows in sequence:

[0059] (1) Take 10.0 mg of the hapten of Example 1, dissolve it in 0.5 ml of dimethylformamide (DMF), stir well, add 8.0 mg of carbodiimide (EDC) and 6.0 mg of N-hydroxysuccinate imide (NHS), stirred at room temperature for 4 hours, the hapten activated ester can be obtained;

[0060] (2) Weigh 43.0mg of ovalbumin (OVA), fully dissolve it in 4ml of PBS solution with a concentration of...

Embodiment 3

[0072] The monoclonal antibody of the nitrofurazone metabolite of present embodiment 3 is prepared by the following method, and its steps are:

[0073] After emulsifying the immunogenic formula (III)-BSA prepared in Example 2 with an equal volume of Freund's adjuvant, immunize BALB / C mice. The immunization dose for each mouse was 50-100 μg, and the immunization interval was 3 weeks. After 3 times of immunization, the blood of the tail vein of the mice was collected to detect the serum titer. If the antibody titer does not reach 60,000, booster immunization is required. After the antibody titer no longer rises, subcutaneous booster immunization is performed with 100 μg of immunogen, and the splenocytes of the mouse are fused with SP20 cells 5 days later. The fused cells were selected in HAT medium, and after 5 days, the complete medium was replaced with HAT medium for culture. Use ELISA to detect the cell supernatant, and carry out the limited dilution clone culture of the cel...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to view more

Abstract

The invention discloses preparation methods and application of semicarbazide SEM derived hapten and artificial antigen. An active arm introduced by the hapten integrally keeps a characteristic structure of an SEM derivative and has no influences on electronic cloud density; the hapten also has an active group capable of being coupled with a carrier protein; reaction conditions are moderate and operation steps are simple; the prepared artificial antigen can be specifically combined with an antibody, and has the characteristics of high valence, high sensitivity, high accuracy and the like; and residues of semicarbazide SEM in various products can be rapidly detected.

Description

technical field [0001] The invention relates to the technical field of immunochemistry, in particular to a preparation method and application of a nitrofurazone metabolite SEM derivatized hapten and an artificial antigen. Background technique [0002] Furans are a class of artificially synthesized antibiotics that share a 5-nitrofuran ring structure, and have antibacterial effects on Gram-positive bacteria, Gram-negative bacteria, and some fungi. Because of its low price, it is widely used in livestock, poultry and fish farming to treat enteritis and coccidiosis caused by Salmonella and Escherichia coli, and is often used as a growth promoter for livestock and aquatic fish and shrimp added to the feed. Nitrofurans mainly include furaltadone, nitrofurazone, nitrofurantoin and furazolidone. However, in terms of food safety, the large or continuous use of nitrofurazone not only has toxic effects on farmed animals, but also has carcinogenic, teratogenic, and mutagenic effects,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C281/14C07K14/765C07K14/77C07K14/795C07K16/44G01N33/577
CPCC07C201/12C07C281/14C07K14/765C07K14/77C07K14/795C07K16/44C07K19/00G01N33/577C07C205/44
Inventor 李斌胡睿
Owner 广州润坤生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products